Live
- Modi lashes out at Congress for committing sins against Constitution
- Cong failed to implement promises: Vinod Kumar
- Rajamahendravaram: MP Margani dares TDP for debate on city development
- Inheriting an art from a trailblazer mom
- Gold rates in Delhi slashes, check the rates on 01 May, 2024
- Gold rates in Visakhapatnam slashes, check the rates on 01 May, 2024
- Gold rates in Vijayawada slashes, check the rates on 01 May, 2024
- Gold rates in Hyderabad slashes, check the rates on 01 May, 2024
- Cong accuses AIMIM & BJP of colluding to maintain their dominance
- Amit Shah to campaign in Hyderabad on behalf of Lok Sabha candidate Madhavi Latha
Dr Reddy's launches generic hypotensive injection in US
Drug firm Dr Reddy's Laboratories on Monday said it has launched in the US Sodium Nitroprusside injection used for immediate reduction of blood pressure in hypertensive crises.
Hyderabad: Drug firm Dr Reddy's Laboratories on Monday said it has launched in the US Sodium Nitroprusside injection used for immediate reduction of blood pressure in hypertensive crises.
The company has launched generic Sodium Nitroprusside injection, 50 mg/2 ml (25 mg/ml) single-dose vial after getting approval from the United States Food and Drug Administration (USFDA), Dr Reddy's Labs said in a filing to the BSE.
The product is a generic version of Hospira Inc's Nitropress injection, 50 mg/2ml, it added. As per IQVIA Health data, Nitropress brand and generics had US sales of around $8 million MAT for the twelve months to October 2019, Dr Reddy's said.
Sodium Nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises.
